Literature DB >> 10036582

Macrophages and pancreatic islet amyloidosis.

E J de Koning1, J J van den Brand, V L Mott, S B Chargé, B C Hansen, N L Bodkin, J F Morris, A Clark.   

Abstract

Islet amyloid formed from islet amyloid polypeptide (IAPP, amylin) is found in spontaneously diabetic monkeys and cats. Islet amyloidosis is progressive, apparently irreversible and is associated with destruction of insulin-secreting cells. The role of macrophages in the destruction and removal of islet amyloid is unknown. Therefore, the presence and morphology of macrophages were determined by electron and quantitative light microscopy in islets of diabetic and nondiabetic man and monkeys and in transgenic mice expressing the gene for human IAPP. Tissue macrophages were present in all pancreatic sections and tissue distribution was similar in exocrine and endocrine areas. There was no difference in macrophage density in amyloidotic and amyloid-free islets in monkeys and man. Macrophage density was similar in islets of transgenic mice expressing human IAPP which do not contain amyloid in vivo but in which fibrils are formed in vitro following islet isolation compared to islets from mice expressing rat IAPP which is not amyloidogenic. IAPP amyloid fibrils were visible by electron microscopy in lysosomes of pancreatic macrophages in man, monkeys and human IAPP transgenic mice. Thus, human IAPP is internalised but inefficiently degraded by tissue macrophages. Diabetes-associated amyloidosis is not associated with visible recruitment of macrophages for removal of amyloid or islet debris.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10036582     DOI: 10.3109/13506129809007297

Source DB:  PubMed          Journal:  Amyloid        ISSN: 1350-6129            Impact factor:   7.141


  15 in total

Review 1.  An immune origin of type 2 diabetes?

Authors:  H Kolb; T Mandrup-Poulsen
Journal:  Diabetologia       Date:  2005-04-30       Impact factor: 10.122

Review 2.  Type 2 diabetes as a protein misfolding disease.

Authors:  Abhisek Mukherjee; Diego Morales-Scheihing; Peter C Butler; Claudio Soto
Journal:  Trends Mol Med       Date:  2015-05-18       Impact factor: 11.951

Review 3.  Islet inflammation in type 2 diabetes and physiology.

Authors:  Kosei Eguchi; Ryozo Nagai
Journal:  J Clin Invest       Date:  2017-01-03       Impact factor: 14.808

Review 4.  NLRP3 inflammasomes link inflammation and metabolic disease.

Authors:  Dominic De Nardo; Eicke Latz
Journal:  Trends Immunol       Date:  2011-07-04       Impact factor: 16.687

Review 5.  Neuroendocrine hormone amylin in diabetes.

Authors:  Xiao-Xi Zhang; Yan-Hong Pan; Yan-Mei Huang; Hai-Lu Zhao
Journal:  World J Diabetes       Date:  2016-05-10

Review 6.  Immune dysfunction in developmental programming of type 2 diabetes mellitus.

Authors:  Thea N Golden; Rebecca A Simmons
Journal:  Nat Rev Endocrinol       Date:  2021-02-01       Impact factor: 43.330

7.  Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes.

Authors:  Seth L Masters; Aisling Dunne; Shoba L Subramanian; Rebecca L Hull; Gillian M Tannahill; Fiona A Sharp; Christine Becker; Luigi Franchi; Eiji Yoshihara; Zhe Chen; Niamh Mullooly; Lisa A Mielke; James Harris; Rebecca C Coll; Kingston H G Mills; K Hun Mok; Philip Newsholme; Gabriel Nuñez; Junji Yodoi; Steven E Kahn; Ed C Lavelle; Luke A J O'Neill
Journal:  Nat Immunol       Date:  2010-09-12       Impact factor: 25.606

Review 8.  Islet amyloid: a complication of islet dysfunction or an aetiological factor in Type 2 diabetes?

Authors:  A Clark; M R Nilsson
Journal:  Diabetologia       Date:  2004-01-13       Impact factor: 10.122

9.  Characterization of the response of primary cells relevant to dialysis-related amyloidosis to β2-microglobulin monomer and fibrils.

Authors:  Morwenna Y Porter; Katy E Routledge; Sheena E Radford; Eric W Hewitt
Journal:  PLoS One       Date:  2011-11-09       Impact factor: 3.240

10.  Human islet amyloid polypeptide transgenic mice: in vivo and ex vivo models for the role of hIAPP in type 2 diabetes mellitus.

Authors:  J W M Höppener; H M Jacobs; N Wierup; G Sotthewes; M Sprong; P de Vos; R Berger; F Sundler; B Ahrén
Journal:  Exp Diabetes Res       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.